Factors associated with the therapeutic efficacy of retinoic acids on malignant lymphomas

Journal of the Formosan Medical Association

Volumn 96, Issue 7, 1997, Pages 525-534

  Cheng, Ann Lii ^a   Chuang, Shuang En ^a   Su, Ih Jen ^b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

malignant lymphoma; retinoic acid; retinoic acid receptor ; T cell; transforming growth factor 1

Indexed keywords

RETINOIC ACID DERIVATIVE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ARTICLE; CELL LINE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; HODGKIN DISEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOMA; T LYMPHOCYTE;

ANTIGENS, CD95; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; ISOTRETINOIN; LYMPHOMA; RECEPTORS, RETINOIC ACID; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0030793235     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Gudas LJ: Retinoids, retinoid-responsive genes, cell differentiation, and cancer. Cell Growth Differ 1992;3:655-62.
2. Lippman SM, Kessler JF, Meyskens Jr FL: Retinoids as preventive and therapeutic anticancer agents (Part I). Cancer Treat Rep 1987;71:391-405.
3. Lippman SM, Kessler JF, Meyskens Jr FL: Retinoids as preventive and therapeutic anticancer agents (Part II). Cancer Treat Rep 1987;71:493-515.
4. Huang ME, Ye YC, Chen SR, et al: Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988;72:567-72.
5. Warrel RP, Frankel SR, Miller WH, et al: Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). New Engl J Med 1991;324:1385-93.
6. Hong WK, Lippman SM, Itri LM, et al: Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. New Engl J Med 1990;323:795-801.
7. Lippman SM, Batsakis JG, Toth BB, et al: Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. New Engl J Med 1993;328:15-20.
8. Lippman SM, Parkinson DR, Itri LM, et al: 13-cis-retinoic acid and interferon-α-2a: effective combination therapy for advanced squamous cell carcinoma of the skin. J Natl Cancer Inst 1992;84:235-41.
9. Lippman SM, Kavanagh JJ, Paredes-Espinoza M, et al: 13-cis-retinoic acid plus interferon α-2a: highly active systemic therapy for squamous cell carcinoma of the cervix. J Natl Cancer Inst 1992;84:241-5.
10. Coonley CJ, Warrel RP, Itri LM: Pilot study of 13-cis-retinoic acid in patients with lymphoma. Proc Am Soc Clin Oncol 1983;3:221. (abstract)
11. Kessler JF, Meysken Jr FL, Levine N, et al: Treatment of cutaneous T-cell lymphoma (mycosis fungoides) with 13-cis-retinoic acid. Lancet 1983;i:1345-7.
12. Chow JM, Cheng AL, Su IJ, et al: 13-cis retinoic acid induces cellular differentiation and durable remission in refractory cutaneous Ki-1 lymphoma. Cancer 1991;67: 2490-4.
13. Su IJ, Cheng AL, Tsai TF, et al: Retinoic acid-induced apoptosis and regression of a refractory Epstein-Barr Virus-containing T cell lymphoma expressing multidrug-resistance phenotypes. Br J Haematol 1993;85:826-8.
14. Cheng AL, Su IJ, Chen CC, et al: Use of retinoic acids in the treatment of peripheral T-cell lymphoma: a pilot study. J Clin Oncol 1994;12:1185-92.
15. Weima SM, van Rooijen MA, Feijen A, et al: Transforming growth factor-β and its receptor are differentially regulated in human embryonal carcinoma cells. Differentiation 1989;41:245-53.
16. Falk LA, Bencdetti FD, Lohrey N, et al: Induction of transforming growth factor-β1 (TGF-β1) receptor expression and TGF-β1 protein production in retinoic acid-treated HL-60 cells: possible TGF-β1-mediated autocrine inhibition. Blood 1991;77:1248-55.
17. Miller WH, Moy D, Li A, et al: Retinoic acid induces down-regulation of several growth factors and proto-oncogenes in a human embryonal cancer cell line. Oncogene 1990;5:511-7.
18. de Groot RP, Pals C, Kruije W: Transcription control of c-jun by retinoic acid. Nucleic Acids Res 1991;19:1585-91.
19. Jaffey P, Chan LL, Shao JY, et al: Retinoic acid inhibition of serum-induced c-fos transcription in a fibrosarcoma cell line. Cancer Res 1992;52:2384-8.
20. Longo L, Pandolfi PP, Biondi A, et al: Rearrangements and aberrant expression of the retinoic acid receptor a gene in acute promyelocytic leukemia. J Exp Med 1990;172:1571-5.
21. Chomienne C, Balitrand N, Ballerini P, et al: All-trans retinoic acid modulates the retinoic acid receptor-α in promyelocytic cells. J Clin Invest 1991;88:2150-4.
22. Pandolfi PP, Grignani F, Alcalay M, et al: Structure and origin of the acute promyelocytic leukemia myl/RARα cDNA and characterization of its retinoid-binding and transactivation properties. Oncogene 1991;6:1285-92.
23. Nutter LM, Cheng AL, Hung HL, et al: Spectrum of anticancer activity and effects on nucleotide metabolism in human neoplastic cell lines. Biochem Pharmacol 1991;41:1283-92.
24. Siegenthaler G, Saurat JH: A slab gel electrophoresis technique for measurement of plasma retinol-binding protein, cellular retinol-binding and retinoic-acid-binding proteins in human skin. Eur J Biochem 1987;166:209-14.
25. Bradford M: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
26. Su IJ, Kadin ME: Expression of growth factor/receptor genes in post-thymic T cell malignancies. Am J Pathol 1989;135:439-45.
27. Kerr IG, Lippman ME, Jenkins J, et al: Pharmacology of 13-cis-retinoic acid in humans. Cancer Res 1982;42:2069-73.
28. Schwab U, Stein H, Gerdes J, et al: Production of a monoclonal antibody specific for Hodgkin and sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 1982;299:65-7.
29. Kadin M: Ki-1-positive anaplastic large-cell lymphoma: a clinicopathologic entity? J Clin Oncol 1991;9:533-6.
30. Stein H, Mason DY: The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985;66:848-58.
31. Kabelitz D, Pohl T, Pechhold K: Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes. Immunol Today 1993;14:338-9.
32. Boylan JF, Gudas LJ: Overexpression of the cellular retinoic acid binding protein-I (CRABP-I) results in a reduction in differentiation-specific gene expression in F9 teratocarcinoma cells. J Cell Biol 1991;112:965-79.
33. Cornic M, Delva L, Guidez F, et al: Induction of retinoic acid-binding protein in normal and malignant human myeloid cells by retinoic acid in acute promyelocytic leukemia patient. Cancer Res 1992;52:3329-34.
34. Adamson PC, Boylan JF, Balis FM, et al: Time course of induction of metabolism of all-trans-retinoic acid and the up-regulation of cellular retinoic acid-binding protein. Cancer Res 1993;53:472-3.
35. Muindi J, Frankel SR, Miller WH, et al: Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentration: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia. Blood 1992;79:299-303.
36. Batova A, Danielpour D, Pirisi L, et al: Retinoic acid induces secretion of latent transforming growth factor β1 and β2 in normal and human papillomavirus type 16-immortalized human keratinocytes. Cell Growth Differ 1992;3:763-72.
37. Newcom SR, Kadin ME, Ansari M: Production of transforming growth factor-β activity by Ki-1 positive lymphoma cells and analysis of its role in the regulation of Ki-1 positive lymphoma growth. Am J Pathol 1988;131:569-77.
38. Leid M, Kastner P, Lyon R, et al: Purification, cloning and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell 1992;68:377-95.
39. Su IJ, Lay JD, Cheng AL, et al: Modulation of retinoic acid receptor α, growth factors and protooncogenes in retinoic acid-induced apoptosis of Ki-1 lymphoma cell line. Int J Oncol 1994;4:1089-95.
40. de The H, del mar Vivanco-Ruiz M, Tiollais P, et al: Identification of a retinoic acid responsive element in the retinoic acid receptor gene. Nature 1990;343:177-80.
41. Umesono K, Murakami KK, Thompson CC, et al: Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell 1991;65:1255-66.
42. Oehm A, Behrmann I, Falk W, et al: Purification and molecular cloning of the Apo-1 cell suflace antigen: a member of the TNF-NGF receptor superfamily. J Biol Chem 1992;15:10709-15.
43. Rieux-Laucat F, Le Deist F, Hivroz C, et al: Mutation in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 1995;268:1347-9.